Hao Shen
Biotech / Biopharma Analyst
- Role
- Biotech Biopharma Associate at Wells Fargo
- Location
- Edison, NJ, US
- LinkedIn followers
- 500 followers
About Hao Shen
Hao Shen, Ph.D. MBA has more than a decade of pharmaceutical and financial industry experience as a R&D scientist, strategy consultant, and equity researcher. Looking forward, Hao is passionated to generate alpha in healthcare investment, advance innovative medicines, and ultimately make incurable disease curable. Currently, Hao is an equity researcher at Wells Fargo, focusing on biopharma and biotech (Argenx, Incyte, Kymera, Soleno, Kyverna, etc.). Prior to joining Wells Fargo, Hao was pharma / biotech equity analyst at Artia, Bank of America & Jefferies, strategy consultant at Bayer, and formulation scientist at Corteva / Dow.Hao holds an MBA from Kellogg School of Management, Northwestern University and a Ph.D. from University of Illinois. Hao\'s Ph.D. research focused on biopharma drug delivery systems (e.g, micelles, lipid nanoparticles) for cancer therapy, gene therapy etc.
Experience
Biotech Biopharma Associate
Jan 2025 — Present · NY, US
Education
Northwestern University - Kellogg School of Management
Master of Business Administration - MBA, Finance, Strategy, Entrepreneurship
2017 — 2019
University of Illinois Chicago
Doctor of Philosophy (PhD), Biopharmaceutical Drug Delivery
South China University of Technology
Bachelor's degree, Polymer Science and Engineering
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.